{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:50:41Z","timestamp":1758819041645,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.cellimm.2014.06.003","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T10:19:36Z","timestamp":1403086776000},"page":"116-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Interleukin-28A promotes IFN-\u03b3 production by peripheral blood mononuclear cells from patients with Beh\u00e7et\u2019s disease"],"prefix":"10.1016","volume":"290","author":[{"given":"Bing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chufang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao Bo","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2014.06.003_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0015","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.4049\/jimmunol.174.4.1932","article-title":"IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29","volume":"174","author":"Siren","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0020","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","article-title":"Lambda interferon inhibits hepatitis B and C virus replication","volume":"79","author":"Robek","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0025","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.4049\/jimmunol.180.4.2474","article-title":"An important role for type III interferon (IFN-lambda\/IL-28) in TLR-induced antiviral activity","volume":"180","author":"Ank","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0030","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.4049\/jimmunol.178.8.5086","article-title":"IL-28 elicits antitumor responses against murine fibrosarcoma","volume":"178","author":"Numasaki","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0035","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.4049\/jimmunol.176.12.7686","article-title":"Antitumor activity of IFN-lambda in murine tumor models","volume":"176","author":"Sato","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0040","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-2184.2008.00558.x","article-title":"Regulation of apoptosis by type III interferons","volume":"41","author":"Li","year":"2008","journal-title":"Cell Prolif."},{"key":"10.1016\/j.cellimm.2014.06.003_b0045","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.4161\/cbt.7.7.6192","article-title":"IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK\/STAT signaling activity","volume":"7","author":"Maher","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cellimm.2014.06.003_b0050","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.gastro.2006.10.028","article-title":"IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet","volume":"132","author":"Siebler","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cellimm.2014.06.003_b0055","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Behcet\u2019s disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2014.06.003_b0060","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.revmed.2009.04.014","article-title":"Ocular manifestations of Behcet\u2019s disease","volume":"31","author":"Saadoun","year":"2010","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.cellimm.2014.06.003_b0065","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/02713680500263606","article-title":"Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China","volume":"30","author":"Yang","year":"2005","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.cellimm.2014.06.003_b0070","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/bjo.87.10.1264","article-title":"T-bet expression is upregulated in active Behcet\u2019s disease","volume":"87","author":"Li","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0075","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2014.06.003_b0080","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2014.06.003_b0085","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.cellimm.2014.06.003_b0090","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","article-title":"Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease","volume":"128","author":"Geri","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0095","first-page":"1078","article-title":"Criteria for diagnosis of Behcet\u2019s disease. International study group for Behcet\u2019s disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2014.06.003_b0100","doi-asserted-by":"crossref","first-page":"G960","DOI":"10.1152\/ajpgi.00126.2005","article-title":"IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression","volume":"289","author":"Brand","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cyto.2005.04.003","article-title":"Biological activity of interleukins-28 and -29: comparison with type I interferons","volume":"31","author":"Meager","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.cellimm.2014.06.003_b0110","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.bbrc.2006.04.043","article-title":"Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells","volume":"344","author":"Zitzmann","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellimm.2014.06.003_b0115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/emmm.201100142","article-title":"IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease","volume":"3","author":"Koltsida","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cellimm.2014.06.003_b0120","doi-asserted-by":"crossref","first-page":"267971","DOI":"10.1155\/2013\/267971","article-title":"IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection","volume":"2013","author":"Tsai","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/intimm\/dxm135","article-title":"Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis","volume":"20","author":"Yoshimura","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/gene.2009.72","article-title":"Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines","volume":"10","author":"Witte","year":"2009","journal-title":"Genes Immun."},{"key":"10.1016\/j.cellimm.2014.06.003_b0135","doi-asserted-by":"crossref","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cellimm.2014.06.003_b0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.gene.6364372","article-title":"Interferon lambda-1 (IFN-lambda1\/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner","volume":"8","author":"Pekarek","year":"2007","journal-title":"Genes Immun."},{"key":"10.1016\/j.cellimm.2014.06.003_b0145","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1182\/blood-2005-10-4129","article-title":"Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells","volume":"107","author":"Mennechet","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2014.06.003_b0150","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1182\/blood-2008-09-179507","article-title":"IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells","volume":"113","author":"Dai","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2014.06.003_b0155","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/JVI.80.10.5032-5040.2006","article-title":"Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus","volume":"80","author":"Chi","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2014.06.003_b0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.gene.6364348","article-title":"Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1\/IL-29)","volume":"8","author":"Jordan","year":"2007","journal-title":"Genes Immun."},{"key":"10.1016\/j.cellimm.2014.06.003_b0165","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/jir.2010.0081","article-title":"The lambda interferons: guardians of the immune-epithelial interface and the T-helper 2 response","volume":"30","author":"Gallagher","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cellimm.2014.06.003_b0170","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-lambda production in asthma exacerbations","volume":"12","author":"Contoli","year":"2006","journal-title":"Nat. Med."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874914001038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874914001038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:51:55Z","timestamp":1757803915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874914001038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0008874914001038"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2014.06.003","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-28A promotes IFN-\u03b3 production by peripheral blood mononuclear cells from patients with Beh\u00e7et\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2014.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}